DAVITA INC. Business Acquisition, Pro Forma Earnings Per Share, Diluted
DAVITA INC. (DVA) reported Business Acquisition, Pro Forma Earnings Per Share, Diluted of $9.58 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted · last filed 2026-02-11
- DAVITA INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2017-09-30 was -$1.13, a 140.79% decline year-over-year.
- DAVITA INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2017-06-30 was $0.66, a 135.71% increase year-over-year.
- DAVITA INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2016-09-30 was $2.77, a 166.35% increase year-over-year.
- DAVITA INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2016-06-30 was $0.28, a 64.56% decline year-over-year.
- DAVITA INC. business acquisition, pro forma earnings per share, diluted for fiscal 2025 was $9.58, a 13.77% decline from fiscal 2024.
- DAVITA INC. business acquisition, pro forma earnings per share, diluted for fiscal 2024 was $11.11, a 41.35% increase from fiscal 2023.
- DAVITA INC. business acquisition, pro forma earnings per share, diluted for fiscal 2023 was $7.86, a 36.93% increase from fiscal 2022.
- DAVITA INC. business acquisition, pro forma earnings per share, diluted for fiscal 2022 was $5.74, a 35.87% decline from fiscal 2021.
| Period end | Business Acquisition, Pro Forma Earnings Per Share, Diluted 3 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 3 month as first filed | Business Acquisition, Pro Forma Earnings Per Share, Diluted 6 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 6 month as first filed | Business Acquisition, Pro Forma Earnings Per Share, Diluted 9 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 9 month as first filed | Business Acquisition, Pro Forma Earnings Per Share, Diluted 12 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $9.58 10-K · filed 2026-02-11 | |||||||
| 2024-12-31 | $11.11 10-K · filed 2026-02-11 | $10.92 10-K · filed 2025-02-13 | ||||||
| 2023-12-31 | $7.86 10-K · filed 2025-02-13 | $7.46 10-K · filed 2024-02-14 | ||||||
| 2022-12-31 | $5.74 10-K · filed 2024-02-14 | $5.70 10-K · filed 2023-02-22 | ||||||
| 2021-12-31 | $8.95 10-K · filed 2023-02-22 | $8.97 10-K · filed 2022-02-11 | ||||||
| 2020-12-31 | $6.51 10-K · filed 2022-02-11 | $6.44 10-K · filed 2021-02-12 | ||||||
| 2019-12-31 | $4.67 10-K · filed 2021-02-12 | $4.61 10-K · filed 2020-02-21 | ||||||
| 2018-12-31 | $3.71 10-K · filed 2020-02-21 | $3.68 10-K · filed 2019-02-22 | ||||||
| 2017-12-31 | $4.82 10-K · filed 2019-02-22 | $4.74 10-K · filed 2018-02-23 | ||||||
| 2017-09-30 | -$1.13 10-Q · filed 2017-11-07 | $1.86 10-Q · filed 2017-11-07 | ||||||
| 2017-06-30 | $0.66 10-Q · filed 2017-08-01 | $2.98 10-Q · filed 2017-08-01 | ||||||
| 2016-12-31 | $5.14 10-K · filed 2018-02-23 | $4.32 10-K · filed 2017-02-24 | ||||||
| 2016-09-30 | $2.77 10-Q · filed 2017-11-07 | $2.76 10-Q · filed 2016-11-02 | $3.51 10-Q · filed 2017-11-07 | $3.55 10-Q · filed 2016-11-02 | ||||
| 2016-06-30 | $0.28 10-Q · filed 2017-08-01 | $0.27 10-Q · filed 2016-08-08 | $0.77 10-Q · filed 2017-08-01 | $0.75 10-Q · filed 2016-08-08 | ||||
| 2016-03-31 | $0.47 10-Q · filed 2016-05-04 | |||||||
| 2015-12-31 | $1.30 10-K · filed 2017-02-24 | $1.27 10-K · filed 2016-02-26 | ||||||
| 2015-09-30 | $1.04 10-Q · filed 2016-11-02 | $1.41 10-Q · filed 2016-11-02 | ||||||
| 2015-06-30 | $0.79 10-Q · filed 2016-08-08 | $0.30 10-Q · filed 2016-08-08 | ||||||
| 2015-03-31 | -$0.51 10-Q · filed 2016-05-04 | |||||||
| 2014-12-31 | $3.41 10-K · filed 2016-02-26 | $3.38 10-K · filed 2015-02-26 | ||||||
| 2013-12-31 | $3.03 10-K · filed 2015-02-26 | $4.70 10-K · filed 2014-02-21 | ||||||
| 2012-12-31 | $4.02 10-K · filed 2014-02-21 | $7.91 10-K · filed 2013-03-01 | ||||||
| 2011-12-31 | $8.48 10-K · filed 2013-03-01 | $5.39 10-K · filed 2012-02-24 | ||||||
| 2011-09-30 | $3.66 10-Q · filed 2011-11-04 | |||||||
| 2010-12-31 | $4.58 8-K · filed 2012-07-06 | $4.05 10-K · filed 2011-02-25 | ||||||
| 2010-09-30 | $3.51 10-Q · filed 2011-11-04 | |||||||
| 2009-12-31 | $4.19 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |